Vice President, Manufacturing
Daniel brings over 25 years of professional experience in bioprocess development, biopharmaceutical manufacturing and bio-processing equipment design and manufacturing to Advantagene. He is among the country’s thought leaders in the manufacture of viral vectors, with particular expertise in adenovirus production and analytical methods, having worked for 11 years at Canji, the gene therapy arm of Schering–Plough Corporation. At Canji he was instrumental in quantifying molecular diffusion in the adenovirus infection process and for the production of purified adenovirus vectors for clinical studies under a California FDB license. More recently, Daniel was Vice President of Research and Development at PBS Biotech, a manufacturer of single-use bioreactors, where he oversaw the product development of a scalable line of single use bioreactors. Daniel holds a B.Sc. in Biochemistry and a B.Sc.A in Chemical Engineering, both from the University of Ottawa.
|Board of Directors|